Netherlands based Ceradis Crop Protection B.V., a global developer and marketer of environmentally friendly plant nutrition and crop protection solutions, has formed a distribution partnership with WinField® United for its CeraMax® bio fungicide seed treatment.
“We are excited about the partnership with WinField United which is an important milestone in commercializing CeraMax in the U.S.,” says Jan Stechmann, Vice President of Marketing and Sales. “This collaboration is a testament to both company’s commitment to the future of biotechnology and a shared goal in delivering effective and environmentally friendly solutions to growers.”
CeraMax is a new biological seed treatment for the prevention of soilborne fungal diseases including Rhizoctonia and Fusarium virguliforme, the causal agent of Sudden Death Syndrome (SDS) in soybeans.
Containing the active ingredient Natamycin, CeraMax empowers the genetic potential of crops to increase early-season vigor for a stronger and more uniform emergence at the start-up of the season.
Registered by the Environmental Protection Agency as a bio fungicide seed treatment for soybeans, CeraMax recently received the government’s stamp of approval for expanding its label to now include corn and wheat.
Progressive Partnering
WinField United, which has an established track record for bringing innovations to growers, plans to market and sell CeraMax in 2021 in soybean-producing areas most impacted by SDS in years past.
“We are continuously searching for novel technologies that maximize grower return on investment,” says Ashley Giese, Marketing Manager of Seed Treatment with WinField United. “Our objective is to provide growers with seed treatment offerings that are driven by innovation, performance, and value. We believe CeraMax helps us deliver on that strategy.”
Giese also says, the agreement with Ceradis not only strengthens her company’s mission in delivering next-generation products to customers but enhances the company’s rapidly growing seed treatment portfolio.
The newly-formed partnership between the organizations represents an important validation in regards to the growing demand for biological inputs in the U.S.